Insider · CIK 0001760104

Cardama Alfonso Quintas

Reports to the SEC for 2 companies · WATERTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001760104

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-30	FHTXFoghorn Therapeutics Inc. · Stock option (right to buy)A Award	Chief Medical Officer	AAward	+300K sh	$5.71	+$1.71M	300,000
2025-01-22	FHTXFoghorn Therapeutics Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+125K sh	$4.37	+$546K	125,000
2024-01-24	FHTXFoghorn Therapeutics Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+60K sh	$3.06	+$184K	60,000
2023-09-11	FHTXFoghorn Therapeutics Inc. · Stock Options (Right to buy)A Award	Chief Medical Officer	AAward	+272K sh	$7.57	+$2.06M	272,000
2023-06-01	TCR2 THERAPEUTICS INC.Restricted Stock UnitD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−11.8K sh	—	—	0
2023-06-01	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−115K sh	—	—	0
2023-06-01	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−90.7K sh	—	—	0
2023-06-01	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−42.3K sh	—	—	0
2023-06-01	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−31.6K sh	—	—	0
2023-06-01	TCR2 THERAPEUTICS INC.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−109K sh	—	—	0
2023-06-01	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−70.6K sh	—	—	0
2023-06-01	TCR2 THERAPEUTICS INC.Restricted Stock UnitD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−9,549 sh	—	—	0
2023-06-01	TCR2 THERAPEUTICS INC.Restricted Stock UnitD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−6,489 sh	—	—	0
2023-06-01	TCR2 THERAPEUTICS INC.Restricted Stock UnitD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−1,409 sh	—	—	0
2022-12-15	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+70.6K sh	—	—	70,649
2022-12-15	TCR2 THERAPEUTICS INC.Restricted Stock Unit (Right to Buy)A Award	Chief Medical Officer	AAward	+11.8K sh	—	—	11,775
2022-12-13	TCR2 THERAPEUTICS INC.S Sale	Chief Medical Officer	SSale	−4,752 sh	$1.06	−$5,041.872	109,459
2022-12-12	TCR2 THERAPEUTICS INC.S Sale	Chief Medical Officer	SSale	−4,586 sh	$1.10	−$5,040.014	114,211
2022-12-09	TCR2 THERAPEUTICS INC.S Sale	Chief Medical Officer	SSale	−4,461 sh	$1.13	−$5,040.93	118,797
2022-12-08	TCR2 THERAPEUTICS INC.S Sale	Chief Medical Officer	SSale	−4,014 sh	$1.26	−$5,041.584	123,258
2022-12-07	TCR2 THERAPEUTICS INC.S Sale	Chief Medical Officer	SSale	−3,928 sh	$1.28	−$5,039.624	127,272
2022-12-06	TCR2 THERAPEUTICS INC.S Sale	Chief Medical Officer	SSale	−3,778 sh	$1.33	−$5,039.852	131,200
2022-12-05	TCR2 THERAPEUTICS INC.S Sale	Chief Medical Officer	SSale	−3,686 sh	$1.37	−$5,049.82	134,978
2022-12-02	TCR2 THERAPEUTICS INC.S Sale	Chief Medical Officer	SSale	−3,636 sh	$1.39	−$5,054.04	138,664
2022-12-01	TCR2 THERAPEUTICS INC.Restricted Stock UnitM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+17.5K sh	—	—	6,489
2022-12-01	TCR2 THERAPEUTICS INC.Restricted Stock UnitM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+69K sh	—	—	1,409
2022-12-01	TCR2 THERAPEUTICS INC.Restricted Stock UnitM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+8,815 sh	—	—	9,549
2022-12-01	TCR2 THERAPEUTICS INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+95.4K sh	—	—	142,300
2022-11-17	TCR2 THERAPEUTICS INC.Restricted Stock Unit (right to buy)A Award	Chief Medical Officer	AAward	+1,933 sh	—	—	1,933
2022-11-17	TCR2 THERAPEUTICS INC.Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−5,799 sh	—	—	0
2022-11-17	TCR2 THERAPEUTICS INC.Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−206K sh	—	—	0
2022-11-17	TCR2 THERAPEUTICS INC.Restricted Stock Unit (right to buy)A Award	Chief Medical Officer	AAward	+68.5K sh	—	—	68,501
2022-11-17	TCR2 THERAPEUTICS INC.Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−3,308 sh	—	—	0
2022-11-17	TCR2 THERAPEUTICS INC.Restricted Stock Unit (right to buy)A Award	Chief Medical Officer	AAward	+1,103 sh	—	—	1,103
2022-11-17	TCR2 THERAPEUTICS INC.Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−68.8K sh	—	—	0
2022-11-17	TCR2 THERAPEUTICS INC.Restricted Stock Unit (right to buy)A Award	Chief Medical Officer	AAward	+22.9K sh	—	—	22,931
2022-11-17	TCR2 THERAPEUTICS INC.Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−4,486 sh	—	—	0
2022-11-17	TCR2 THERAPEUTICS INC.Restricted Stock Unit (right to buy)A Award	Chief Medical Officer	AAward	+816 sh	—	—	816
2022-11-17	TCR2 THERAPEUTICS INC.Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−96.5K sh	—	—	0
2022-11-17	TCR2 THERAPEUTICS INC.Restricted Stock Unit (right to buy)A Award	Chief Medical Officer	AAward	+17.5K sh	—	—	17,548
2021-12-09	TCR2 THERAPEUTICS INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+43K sh	$0.74	+$31.8K	46,915
2021-12-09	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+115K sh	—	—	114,700
2021-12-09	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+43K sh	$0.74	+$31.8K	31,582
2021-08-31	TCR2 THERAPEUTICS INC.A Award	Chief Medical Officer	AAward	+164 sh	$14.26	+$2,338.64	3,915
2021-02-28	TCR2 THERAPEUTICS INC.A Award	Chief Medical Officer	AAward	+708 sh	$16.12	+$11.4K	3,751
2020-12-10	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+101K sh	—	—	101,000
2020-08-31	TCR2 THERAPEUTICS INC.A Award	Chief Medical Officer	AAward	+1,118 sh	$10.10	+$11.3K	3,043
2020-02-28	TCR2 THERAPEUTICS INC.A Award	Chief Medical Officer	AAward	+1,082 sh	$10.10	+$10.9K	1,925
2019-12-19	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	−72.1K sh	—	—	72,100
2019-08-30	TCR2 THERAPEUTICS INC.A Award	Chief Medical Officer	AAward	+843 sh	$12.75	+$10.7K	843

Recent filings

Accepted (ET)
Feb 24
Cardama Alfonso Quintas0001760104-26-000002
SEC(opens sec.gov)
Jan 244
Cardama Alfonso Quintas0001562180-25-000506
SEC(opens sec.gov)
Jan 254
Cardama Alfonso Quintas0001562180-24-000609
SEC(opens sec.gov)
Sep 134
Cardama Alfonso Quintas0001562180-23-006837
SEC(opens sec.gov)
Jun 14
Cardama Alfonso Quintas0001104659-23-067068
SEC(opens sec.gov)
Dec 194
Cardama Alfonso Quintas0000899243-22-039033
SEC(opens sec.gov)
Dec 134
Cardama Alfonso Quintas0000899243-22-038387
SEC(opens sec.gov)
Dec 94
Cardama Alfonso Quintas0000899243-22-038102
SEC(opens sec.gov)

Companies

Address

99 COOLIDGE AVENUE SUITE 500

WATERTOWN, MA, 02472